Top Markets
Coin of the day
Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.

Syngen Biotech Co.,Ltd.

8279
Clasificación en acciones #23466
Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd.... Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd. operates globally, including in Taiwan and China, specializing in the research, development, production, and sale of a diverse array of products. Its core offerings include microbial pharmaceutical raw materials, biological pesticides, fertilizers, biochemical nutritional products, and preventive medicines. The company further manufactures dietary supplements and provides comprehensive contract manufacturing services for supplements, accommodating various formats such as sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies. Syngen Biotech also develops and markets science-backed bioactive pharmaceutical ingredients (APIs) under proprietary brands including Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL. Additional services encompass private labelling, organic food OEM/ODM, explosion-proof extraction, brand agency, and wholesale distribution. Syngen Biotech caters to numerous industries, such as sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox. The company actively exports its products to approximately 20 countries worldwide.
Precio por acción
$2.70
Última sincronización: 2026-08-21
Capitalización bursátil
$73.25M
Cambio (1 día)
0.24%
Cambio (1 año)
-34.30%
País
TW
Comercio Syngen Biotech Co.,Ltd. (8279)

Categoría

Ganancias de Syngen Biotech Co.,Ltd. (8279)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Syngen Biotech Co.,Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Syngen Biotech Co.,Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$-4.02B -
AU
- -
CH